Skip to main content
Intermediate Technical In the Industry Vocabulary Test

gadolinium contrast

MRI contrast agents containing gadolinium chelates used to enhance vascular structures and tissue perfusion in magnetic resonance imaging.

Full Definition

Gadolinium-based contrast agents (GBCAs) are paramagnetic compounds used in magnetic resonance imaging to improve visualization of vascular structures and tissue enhancement patterns. These agents work by shortening T1 relaxation times, resulting in increased signal intensity on T1-weighted images. In vascular imaging, gadolinium contrast enables contrast-enhanced MRA and dynamic perfusion studies. GBCAs are generally safer than iodinated contrast agents in patients with renal dysfunction, though they carry a risk of nephrogenic systemic fibrosis in patients with severe kidney disease. Different formulations have varying stability and biodistribution properties.

Usage

Usage note: Distinguish from gadolinium enhancement, which refers to the imaging finding.

In Context

  • "Gadolinium contrast was administered for the MRA examination of the renal arteries." — MRI protocol documentation
  • "The lesion showed early enhancement following gadolinium contrast injection." — MRI report

Also known as

GBCA MRI contrast gadolinium-based contrast agent

Contrasted with

iodinated contrast

Don't confuse with

iodinated contrast gadolinium enhancement

Editors from these organizations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON